Warning letterFDA · May 3, 2023
iSlim, LLC MARCS-CMS 655819, May 03, 2023
Named company: iSlim, LLC
As described below, this product is an unapproved new drug sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore, your…
